|
🐜
|
Is there a role for the laboratory monitoring in the management of specific antidotes of direct oral anticoagulants?
11 auth.
Nicolas Gendron,
Paul Billoir,
Virginie Siguret,
V. Le Cam-Duchez,
Valérie Proulle,
Laurent Macchi,
...
Elodie Boissier,
Christine Mouton,
E. de Maistre,
I. Gouin-Thibault,
Georges Jourdi
|
2 |
2024 |
2
🐜
|
|
🐜
|
Management of Therapeutic-intensity Unfractionated Heparin: A Narrative Review on Critical Points
9 auth.
I. Gouin-Thibault,
Alexandre Mansour,
M. Hardy,
P. Gueret,
E. de Maistre,
Virginie Siguret,
...
Adam Cuker,
F. Mullier,
Thomas Lecompte
|
2 |
2024 |
2
🐜
|
|
🐜
|
THE USE OF 1E12, A MONOCLONAL ANTI-PLATELET FACTOR 4 ANTIBODY TO IMPROVE THE DIAGNOSIS OF VACCINE-INDUCED IMMUNE THROMBOTIC THROMBOCYTOPENIA.
24 auth.
C. Vayne,
J. Rollin,
R. Clare,
Mercy Daka,
M. Atsouawe,
E. Guéry,
Philippe Cauchie,
C. Cordonnier,
Pauline Cuisenier,
E. de Maistre,
...
Magali Donnard,
N. Drillaud,
D. Faille,
Hubert Galinat,
I. Gouin-Thibault,
S. Lemoine,
Guillaume Mourey,
F. Mullier,
Virginie Siguret,
S. Susen,
A. Godon,
I. Nazy,
Y. Gruel,
C. Pouplard
|
1 |
2024 |
1
🐜
|
